Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed director
Quarterly results
CC transcript
|
|
ENDOLOGIX INC (ELGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/28/2018 |
GN
| New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 06/28/2018 |
GN
| Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises — Emerging Consolidated Expectations, Analyst Ratings |
| 02/12/2018 |
GN
| Detailed Research: Economic Perspectives on Haemonetics, Endologix, NRG Yield, Cirrus Logic, Macquarie Infrastructure, and Shake Shack — What Drives Growth in Today's Competitive Landscape |
| 12/19/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Endologix, Haemonetics, Prudential Financial, AdvanSix, PolyOne, and Rexford Industrial Realty — New Research Emphasizes Economic Growth |
| 03/03/2017 |
GN
| EGLX UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endologix, Inc. and a Lead Plaintiff Deadline of March 6, 2017 |
| 02/24/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Endologix, Inc. and Certain Officers – ELGX |
| 02/22/2017 |
GN
| Endologix Reports Results for the Fourth Quarter and Full Year 2016 |
| 02/15/2017 |
GN
| ENDOLOGIX LOSS NOTICE: Rosen Law Firm Reminds Endologix Inc. Investors of Important Deadline in Class Action Filed by Firm - ELGX |
| 02/14/2017 |
GN
| Endologix Completes Patient Enrollment in the Ovation® LUCY Study |
| 02/07/2017 |
GN
| Endologix to Report Fourth Quarter and Full Year 2016 Financial Results on February 22, 2017 |
| 02/03/2017 |
GN
| Endologix to Present at Leerink Partners 6th Annual Global Healthcare Conference |
| 02/03/2017 |
GN
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Endologix Inc. (ELGX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit |
| 01/30/2017 |
GN
| ELGX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endologix, Inc. and a Lead Plaintiff Deadline of March 6, 2017 |
| 01/27/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endologix, Inc. of Class Action Lawsuit and Upcoming Deadline – ELGX |
| 10/01/2012 |
GN
| Endologix Appoints Charles Love Vice President of Clinical Affairs |
| 07/26/2012 |
GN
| Endologix Reports 33% Revenue Growth for the Second Quarter 2012 |
| 07/20/2012 |
GN
| Endologix to Report Second Quarter 2012 Financial Results and Provide Operational and Product Pipeline Updates on July 26, 2012 |
| 05/30/2012 |
GN
| Endologix Announces Public Offering of 2.7 Million Shares of Common Stock |
| 04/26/2012 |
GN
| Endologix Reports 32% Revenue Growth for the First Quarter 2012 |
| 04/12/2012 |
GN
| Endologix to Report First Quarter 2012 Financial Results on April 26, 2012 |
| 03/05/2012 |
GN
| Endologix to Present at 24th Annual ROTH Conference |
| 02/22/2012 |
GN
| Endologix Reports 24% and 22% Revenue Growth for the Full Year and Fourth Quarter 2011 |
| 02/10/2012 |
GN
| Endologix to Report Fourth Quarter and Full Year 2011 Financial Results on February 22, 2012 |
| 02/09/2012 |
GN
| Endologix Completes Enrollment in PEVAR Randomized Trial |
| 01/31/2012 |
GN
| Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial |
| 01/03/2012 |
GN
| Endologix to Present at the 30th Annual J.P. Morgan Healthcare Conference |
| 11/21/2011 |
GN
| Endologix to Present at Three Upcoming Investor Conferences |
| 11/08/2011 |
GN
| Endologix to Present at Two Upcoming Conferences |
| 10/27/2011 |
GN
| Endologix Reports 25% Third Quarter 2011 Revenue Growth |
| 10/18/2011 |
GN
| Endologix to Report Third Quarter 2011 Financial Results on October 27, 2011 |
| 09/22/2011 |
GN
| Endologix to Present at the Jefferies 2011 Global Healthcare Conference |
| 09/06/2011 |
GN
| Endologix to Present at Three Upcoming Conferences |
| 09/06/2011 |
GN
| Endologix Receives IDE Approval for the Ventana(TM) Fenestrated Stent Graft System |
| 08/30/2011 |
GN
| Endologix Appoints Ruth Lyons Vice President of Global Marketing |
|
|